[Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone]. 1979

U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler

In seven patients with uncomplicated essential hypertension the effects of an acute alpha-adrenergic blockade, alone and combined with a chronic beta-adrenergic blockade, on blood pressure, renal function as measured by standard clearance methods, plasma renin activity, and plasma aldosterone were evaluated. Acute alpha-adrenergic blockade with phentolamine (20 mg by intravenous infusion) significantly enhanced the antihypertensive effect of chronic beta-adrenergic blockade with slow-oxprenolol (160 mg/ day X 14 days) (- 14.5% verus - 7.4% for pulse pressure, - 12.4% versus - 6.0% for diastolic pressure, 2 alpha less than 0.05). Under combined adrenergic blockade renal plasma flow increased, glomerular filtration rate and filtration fraction decreased (2 alpha less than 0.05 each), whereas the fractional clearances of sodium, potassium, free water, and solute load remained unchanged. The activation of the renin-angiotensin-axis, elicited by alpha-adrenergic blockade alone, was suppressed by the preceding beta-adrenergic blockade. These findings demonstrate a favourable antihypertensive action of a combined blockade of alpha- und beta-adrenergic receptor sites without untoward side effects on renal function or the renin-angiotensin-axis.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses

Related Publications

U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
February 1987, Journal of clinical pharmacology,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
December 1976, Clinical science and molecular medicine. Supplement,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
October 1975, Klinische Wochenschrift,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
August 1976, Clinical pharmacology and therapeutics,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
January 1982, Journal of cardiovascular pharmacology,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
October 1976, Circulation research,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
October 1982, European journal of clinical pharmacology,
U Grüninger, and R Akert, and H Hunkeler, and E Wegmüller, and P Weidmann, and J Hodler
June 1975, Circulation research,
Copied contents to your clipboard!